U.S. markets open in 5 hours 7 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
96.20+2.18 (+2.32%)
At close: 04:00PM EST
96.26 +0.06 (+0.06%)
Pre-Market: 04:19AM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close94.02
Bid0.00 x 900
Ask0.00 x 800
Day's Range92.58 - 97.47
52 Week Range62.55 - 163.24
Avg. Volume5,022,635
Market Cap36.755B
Beta (5Y Monthly)1.68
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
10% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for MRNA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Moderna, Inc.
    Analyst Report: Moderna IncModerna Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious and cardiovascular diseases, rare diseases, immunological conditions, and cancer. The company has approximately 5,150 employees.
    Fair Value
    Economic Moat
    22 hours agoArgus Research
View more